The FDA issued this update on Jan. 22. Cal Yee Farm LLC first recalled an array of chocolate and yogurt-covered products on December 12, 2024, along with other dried fruit, nut mixes, and snacks ...

Jan. 31, 2025 – The FDA has approved a new non-opioid oral drug for acute pain in adults. It is the first new class of non-opioid pain medicine approved in over 20 years, providing effective ...

Jan 30 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.

An audit released by the Inspector General of the U.S. Department of Health and Human Services, the parent organization of the Food and Drug Administration (FDA), is not a pleasant read. Let us turn ...

It’s not clear if the changes are temporary or if the pages will be restored. When asked about the removed webpages, an FDA spokesperson directed MedTech Dive to contact the Department of Health and ...

The page for Project Equity, a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that cancer drugs were evaluated for approval based on data from a diverse group of ...

While this falls short of the FDA’s designation of being “approved” as generally safe, it allows ZYN to continue selling its three- and six-milligram nicotine pouches in 10 different flavors ...

The FDA declined to comment, citing a communications pause by the HHS. Brenner will lead the agency until a permanent commissioner is installed. President Donald Trump has nominated Johns Hopkins ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The FDA's Diversity Action Plan draft guidance to drug and medical device companies stems from the 2022 Food and Drug Omnibus Reform Act. It aims to significantly increase participation of ...